Dipna Pharmachem Ltd — Important, 26-11-2025: Company Update

Dipna Pharmachem has filed its financial results for the quarter and half-year ended September 30, 2025, which were approved by its Board. The company reported a net profit of ₹1.41 Cr for the half-year. Total equity stands at ₹58.09 Cr, including ₹18.98 Cr from share warrant money received. The company confirmed no deviation in the utilization of funds from its ₹11.84 Cr Rights Issue and a ₹18.94 Cr Preferential Issue of convertible warrants. These funds are designated for working capital and general corporate purposes, with no outstanding loan defaults.